A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth ...

Whether you are someone who has lost weight recently or is just someone who is worried about gaining weight during the ...

Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

After flying high during the first half of the year, pharmaceutical giant Eli Lilly (NYSE: LLY) has lost some momentum; the ...

Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and ...